Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Turner Syndrome
Interventions
DRUG

somatotropin

Subjects will receive 5 mg somatotropin (growth hormone) pens with cartridges. Subcutaneous injections are to be given every evening around bedtime. Dosing regimen: 50 mcg/kg/day to be adjusted at 4 month intervals to the closest 0.1 mg. Subjects will be given 12 months of treatment (from 12 to 24 months of life). Subjects will visit their pediatrician or pediatric endocrinologist at 4 and 8 months of life.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Rebecca Knickmeyer Santelli, PhD

OTHER

NCT01367834 - Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome | Biotech Hunter | Biotech Hunter